These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16723200)

  • 1. Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agent.
    Malzert-Fréon A; Vrignaud S; Saulnier P; Lisowski V; Benoît JP; Rault S
    Int J Pharm; 2006 Aug; 320(1-2):157-64. PubMed ID: 16723200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and soft formulation of folate-functionalized nanoparticles for the targeted delivery of tripentone in ovarian carcinoma.
    Tomasina J; Poulain L; Abeilard E; Giffard F; Brotin E; Carduner L; Carreiras F; Gauduchon P; Rault S; Malzert-Fréon A
    Int J Pharm; 2013 Dec; 458(1):197-207. PubMed ID: 24084450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
    Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
    Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the introduction of a solubility enhancer on the formulation of lipidic nanoparticles with improved drug loading rates.
    Malzert-Fréon A; Saint-Lorant G; Hennequin D; Gauduchon P; Poulain L; Rault S
    Eur J Pharm Biopharm; 2010 Jun; 75(2):117-27. PubMed ID: 20144710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion.
    Anton N; Gayet P; Benoit JP; Saulnier P
    Int J Pharm; 2007 Nov; 344(1-2):44-52. PubMed ID: 17592746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity.
    Pulkkinen M; Pikkarainen J; Wirth T; Tarvainen T; Haapa-aho V; Korhonen H; Seppälä J; Järvinen K
    Eur J Pharm Biopharm; 2008 Sep; 70(1):66-74. PubMed ID: 18555675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
    Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
    Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology.
    Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S
    Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices.
    Pawar AA; Chen DR; Venkataraman C
    Int J Pharm; 2012 Jul; 430(1-2):228-37. PubMed ID: 22469694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-loaded glyceryl palmitostearate nanoparticles: in vitro release and cytotoxic activity.
    Shenoy VS; Gude RP; Murthy RS
    J Drug Target; 2009 May; 17(4):304-10. PubMed ID: 19255897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
    Shu S; Zhang X; Teng D; Wang Z; Li C
    Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro.
    Wan F; You J; Sun Y; Zhang XG; Cui FD; Du YZ; Yuan H; Hu FQ
    Int J Pharm; 2008 Jul; 359(1-2):104-10. PubMed ID: 18450394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
    Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
    J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms.
    Perrier T; Saulnier P; Fouchet F; Lautram N; Benoît JP
    Int J Pharm; 2010 Aug; 396(1-2):204-9. PubMed ID: 20600733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural investigations on lipid nanoparticles containing high amounts of lecithin.
    Schubert MA; Harms M; Müller-Goymann CC
    Eur J Pharm Sci; 2006 Feb; 27(2-3):226-36. PubMed ID: 16298113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.